BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 817665)

  • 1. Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity.
    Bodey GP; Rodriguez V; Weaver S
    Antimicrob Agents Chemother; 1976 Apr; 9(4):668-74. PubMed ID: 817665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Wald ER; Standiford HC; Tatem BA; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1975 Mar; 7(3):336-40. PubMed ID: 806263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Aug; 10(2):241-4. PubMed ID: 984764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.
    Lopez CE; Standiford HC; Tatem BA; Calia FM; Schimpff SC; Snyder MJ; Hornick RB
    Antimicrob Agents Chemother; 1977 Mar; 11(3):441-8. PubMed ID: 404963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of piribenicillin, ticarcillin, and carbenicillin against Pseudomonas aeruginosa.
    Murakawa T; Sabath LD
    Antimicrob Agents Chemother; 1977 Jan; 11(1):1-6. PubMed ID: 13704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory studies with a new broad-spectrum penicillin, pirbenicillin.
    Retsema JA; English AR; Lynch JE
    Antimicrob Agents Chemother; 1976 Jun; 9(6):975-82. PubMed ID: 938027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ticarcillin, carbenicillin and ampicillin against some gram-negative bacilli.
    Legakis NJ; Papavassiliou J
    J Antibiot (Tokyo); 1975 Nov; 28(11):912-9. PubMed ID: 811636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.
    Bodey GP; Stewart D
    Appl Microbiol; 1971 Apr; 21(4):710-7. PubMed ID: 4930281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity between inhibitory and killing effects of BL-P1654.
    Kurtz S; Holmes K; Turck M
    Antimicrob Agents Chemother; 1975 Feb; 7(2):215-8. PubMed ID: 1137373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azlocillin: in vitro studies of a new semisynthetic penicillin.
    Stewart D; Bodey GP
    Antimicrob Agents Chemother; 1977 May; 11(5):865-70. PubMed ID: 18083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD; Levison ME; Kaye D
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
    Monif GR; Clark PR; Shuster JJ; Baer H
    Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin: in vitro evaluation.
    Bodey GP; Le Blanc B
    Antimicrob Agents Chemother; 1978 Jul; 14(1):78-87. PubMed ID: 28694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Fass RJ; Prior RB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa.
    Watanakunakorn C; Bannister T
    Antimicrob Agents Chemother; 1974 Oct; 6(4):471-3. PubMed ID: 4157347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro activity of ticarcillin and carbenicillin against 100 clinical isolates of Pseudomonas aeruginosa.
    Pearman JW; Kosaras FP; Harper WE
    Med J Aust; 1978 Apr; 1(8):452-4. PubMed ID: 96319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new pencillin with anti-klebsiella activity: 3-(5-tetrazolyl) penam.
    Bodey GP; Weaver S; Pan T
    J Antibiot (Tokyo); 1977 Sep; 30(9):724-9. PubMed ID: 924895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative "in vitro" activity of pirbenicillin and carbenicillin against clinical and environmental "Pseudomonas aeruginosa" isolates from hospitals.
    Castellani Pastoris M; Mondello F; Gennaro ML; Greco D
    Ann Sclavo; 1980; 22(6):931-9. PubMed ID: 6794465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.